Related Experiment Video

Updated: Jun 1, 2026

A 3D Organotypic Melanoma Spheroid Skin Model
08:49

A 3D Organotypic Melanoma Spheroid Skin Model

Published on: May 18, 2018

Novel targeted therapies for the treatment of metastatic melanoma

Ragini Kudchadkar1

  • 1Department of Cutaneous Oncology, Moffitt Cancer Center, Tampa, FL.

Ochsner Journal
|May 24, 2011
PubMed

Insights

Clinical trials are the standard of care for stage IV metastatic melanoma. Advances in understanding melanoma molecular biology have spurred targeted therapies by inhibiting key signal transduction pathways.

Area of Science:

  • Oncology
  • Molecular Biology
  • Dermatology

Background:

  • National Comprehensive Cancer Network guidelines recommend clinical trials for stage IV metastatic melanoma.
  • Understanding melanoma's molecular biology drives translational research and targeted therapy development.
  • Alterations in signal transduction pathways are crucial in melanoma development.

Purpose of the Study:

  • To review key signal transduction pathway alterations in melanoma.
  • To discuss novel targeted therapies based on molecular biology.
  • To highlight the role of clinical trials as standard of care.

Main Methods:

  • Review of current literature on melanoma molecular biology.
  • Analysis of signal transduction pathways including MAPK, PI3K, and p53/Rb.
  • Examination of emerging targeted therapies.

Main Results:

  • Activated mitogen-activated protein kinase (MAPK) pathway is implicated in melanoma.
  • Activated phosphoinositide 3-kinase (PI3K) pathway contributes to melanoma progression.
  • Inactivated p53/Rb pathways are observed in melanoma.

Conclusions:

  • Targeted therapies inhibiting these pathways represent a significant advancement.
  • Further research into molecular mechanisms will yield more effective treatments.
  • Clinical trials remain the preferred treatment option for stage IV metastatic melanoma.
Keywords:
BRAFMAP kinasePI3 kinasemelanomasorafenib

More Related Videos

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis07:41

A Robust Discovery Platform for the Identification of Novel Mediators of Melanoma Metastasis

Published on: March 8, 2022

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma09:52

Isolated Hepatic Perfusion as a Treatment for Liver Metastases of Uveal Melanoma

Published on: January 25, 2015

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...